Ann Gidner

Ann Ulrika Gidner is currently Chief Executive Officer at Ziccum AB since 2022.
Former roles include Chief Executive Officer at AcuCort AB, Chief Executive Officer at SelectImmune Pharma AB from 2020 to 2022, Director-Sales & Marketing at LANXESS Deutschland GmbH, Life Science Director at Semcon Caran AB, Director-Sales & Business Development at Novozymes Biopharma Sweden AB, Director at SenzaGen AB from 2014 to 2020, Managing Director at Monocl AB, Director-Business Development at Albumedix A, Independent Director at Iconovo AB, Senior Global Business Development Officer at Cambrex Corp., Principal at LANXESS Corp., Principal at Cambrex AB, and Head-CTS Business Unit at Inceptua GmbH.
Education includes graduate and MBA degrees from the University of Lund.